Trevena Inc (TRVN)
1.69
-0.06
(-3.43%)
USD |
OTCM |
Nov 04, 16:00
Trevena Gross Profit Margin (Quarterly): 68.31% for June 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 68.31% |
| March 31, 2024 | -340.0% |
| December 31, 2023 | |
| September 30, 2023 | 2.78% |
| June 30, 2023 | 97.09% |
| March 31, 2023 | -2.02K% |
| December 31, 2022 | |
| September 30, 2022 |
| Date | Value |
|---|---|
| June 30, 2022 | |
| March 31, 2022 | -935.0% |
| December 31, 2021 | |
| September 30, 2021 | -9.94% |
| June 30, 2021 | -44.94% |
| March 31, 2021 | 22.01% |
| December 31, 2020 | -163.8% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
-2.02K%
Minimum
Mar 2023
97.09%
Maximum
Jun 2023
-332.0%
Average
-27.44%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Pfizer Inc | 70.27% |
| United Therapeutics Corp | 88.90% |
| Syndax Pharmaceuticals Inc | -- |
| Arcus Biosciences Inc | -- |
| NovaBay Pharmaceuticals Inc | 66.33% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Assets | -103.6% |
| Return on Invested Capital | -169.0% |
| Profit Margin (Quarterly) | -1.50K% |
| Operating Margin (Quarterly) | -2.00K% |
| Return on Net Operating Assets | -496.1% |